Advertisement

AddendumMetabolism Free access | 10.1172/JCI24335C1

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

Stuart P. Weisberg, Deborah Hunter, Reid Huber, Jacob Lemieux, Sarah Slaymaker, Kris Vaddi, Israel Charo, Rudolph L. Leibel, and Anthony W. Ferrante Jr.

Find articles by Weisberg, S. in: PubMed | Google Scholar

Find articles by Hunter, D. in: PubMed | Google Scholar

Find articles by Huber, R. in: PubMed | Google Scholar

Find articles by Lemieux, J. in: PubMed | Google Scholar

Find articles by Slaymaker, S. in: PubMed | Google Scholar

Find articles by Vaddi, K. in: PubMed | Google Scholar

Find articles by Charo, I. in: PubMed | Google Scholar

Find articles by Leibel, R. in: PubMed | Google Scholar

Find articles by Ferrante, A. in: PubMed | Google Scholar

Published May 1, 2006 - More info

Published in Volume 116, Issue 5 on May 1, 2006
J Clin Invest. 2006;116(5):1457–1457. https://doi.org/10.1172/JCI24335C1.
© 2006 The American Society for Clinical Investigation
Published May 1, 2006 - Version history
View PDF

Original citation: J. Clin. Invest.116:115-124 (2006). doi:10.1172/JCI24335

Citation for this addendum: J. Clin. Invest.116:1457 (2006). doi:10.1172/JCI24335C1

During revision of reference 11 (Brodmerkel, C.M., et al. 2005. Discovery and pharmacological characterization of a novel rodent active CCR2 antagonist, INCB3344. J. Immunol.175:5370-5378.), the structure of INCB3344 was omitted. The structure of INCB3344 follows:

Version history
  • Version 1 (May 1, 2006): No description
Advertisement
Advertisement